SG11202111814XA - Engineered cas9 with broadened dna targeting range - Google Patents

Engineered cas9 with broadened dna targeting range

Info

Publication number
SG11202111814XA
SG11202111814XA SG11202111814XA SG11202111814XA SG11202111814XA SG 11202111814X A SG11202111814X A SG 11202111814XA SG 11202111814X A SG11202111814X A SG 11202111814XA SG 11202111814X A SG11202111814X A SG 11202111814XA SG 11202111814X A SG11202111814X A SG 11202111814XA
Authority
SG
Singapore
Prior art keywords
broadened
dna targeting
engineered cas9
targeting range
range
Prior art date
Application number
SG11202111814XA
Other languages
English (en)
Inventor
Le Cong
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of SG11202111814XA publication Critical patent/SG11202111814XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11202111814XA 2019-04-25 2020-04-24 Engineered cas9 with broadened dna targeting range SG11202111814XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962838498P 2019-04-25 2019-04-25
PCT/US2020/029855 WO2020219908A1 (en) 2019-04-25 2020-04-24 Engineered cas9 with broadened dna targeting range

Publications (1)

Publication Number Publication Date
SG11202111814XA true SG11202111814XA (en) 2021-11-29

Family

ID=72941444

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111814XA SG11202111814XA (en) 2019-04-25 2020-04-24 Engineered cas9 with broadened dna targeting range

Country Status (12)

Country Link
US (1) US20220204954A1 (cg-RX-API-DMAC7.html)
EP (1) EP3958914A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022530055A (cg-RX-API-DMAC7.html)
KR (1) KR20220025708A (cg-RX-API-DMAC7.html)
CN (1) CN114206394A (cg-RX-API-DMAC7.html)
AU (1) AU2020261071A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021021306A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137903A1 (cg-RX-API-DMAC7.html)
IL (1) IL287541A (cg-RX-API-DMAC7.html)
MX (1) MX2021012966A (cg-RX-API-DMAC7.html)
SG (1) SG11202111814XA (cg-RX-API-DMAC7.html)
WO (1) WO2020219908A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
AU2019291918B2 (en) 2018-06-29 2025-06-12 Editas Medicine, Inc. Synthetic guide molecules, compositions and methods relating thereto
US20230295611A1 (en) * 2022-03-01 2023-09-21 Versitech Limited Cas9 protein for genome editing
CN115083532B (zh) * 2022-06-21 2024-08-27 中国科学技术大学 基于分子动力学模拟获取rsv f突变体的方法
CN115927439B (zh) * 2022-08-29 2026-04-21 中国农业科学院作物科学研究所 CRISPR/SaCas9系统在大豆基因编辑中的应用
AU2024309386A1 (en) 2023-06-30 2025-12-18 Christiana Care Gene Editing Institute, Inc. Nras gene knockout for treatment of cancer
CN117866926B (zh) * 2024-03-07 2024-08-16 珠海舒桐医疗科技有限公司 一种CRISPR-FrCas9蛋白突变体及应用
WO2025213016A2 (en) 2024-04-04 2025-10-09 Christiana Care Gene Editing Institute, Inc. Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
WO2025226816A1 (en) 2024-04-23 2025-10-30 Christiana Care Gene Editing Institute, Inc. Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016226077B2 (en) * 2015-03-03 2021-12-23 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases with altered PAM specificity
WO2016205759A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
US9512446B1 (en) * 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
WO2018027078A1 (en) * 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
KR102569848B1 (ko) * 2016-12-23 2023-08-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Pcsk9의 유전자 편집
JP6628387B2 (ja) * 2017-09-05 2020-01-08 国立大学法人 東京大学 改変されたCas9タンパク質及びその用途

Also Published As

Publication number Publication date
MX2021012966A (es) 2022-04-06
CN114206394A (zh) 2022-03-18
AU2020261071A1 (en) 2021-11-25
US20220204954A1 (en) 2022-06-30
EP3958914A4 (en) 2023-07-19
BR112021021306A2 (pt) 2022-02-01
CA3137903A1 (en) 2020-10-29
WO2020219908A1 (en) 2020-10-29
KR20220025708A (ko) 2022-03-03
EP3958914A1 (en) 2022-03-02
IL287541A (en) 2021-12-01
JP2022530055A (ja) 2022-06-27

Similar Documents

Publication Publication Date Title
IL287541A (en) Cas9 is engineered with an extended range of target DNA
AU2016363024B2 (en) Engineered nucleic-acid targeting nucleic acids
IL288956A (en) RN" A building
PL3765615T3 (pl) Nowe enzymy i układy crispr ukierunkowane na dna
ZA202101368B (en) Rna particles comprising polysarcosine
IL291095A (en) Novel crispr dna targeting enzymes and systems
IL282092B (en) Engineered enzymes
PT3765616T (pt) Novas enzimas e sistemas de direcionamento de dna e rna crispr
SG11202001208XA (en) Rna targeting methods and compositions
AU2018289077A1 (en) Nucleic acid-guided nucleases
IL271389B2 (en) Non-viral DNA revenues are targeted
IL276490A (en) Engineered target-specific nucleases
IL284447B2 (en) Dux4 RNA silencing using RNA-targeted CRISPR-Cas13b
LT3612624T (lt) Genų terapija
CA193169S (en) Cannula assembly
HUE056570T2 (hu) Génterápia
GB201905301D0 (en) Gene therapy
GB201913898D0 (en) Nucleic acid construct
IL279685A (en) Gene therapy
EP4010468A4 (en) CAST-MEDIATED DNA TARGETING IN PLANTS
GB201802326D0 (en) Gene therapy
GB201701968D0 (en) Gene therapy
GB201817470D0 (en) Gene therapy
HK40070523A (en) Engineered cas9 with broadened dna targeting range
SG11202109554XA (en) Neuroprotective gene therapy targeting the akt pathway